{"id":973,"date":"2021-11-16T21:30:32","date_gmt":"2021-11-16T20:30:32","guid":{"rendered":"https:\/\/therapeutic-impact.org\/?p=973"},"modified":"2021-11-16T21:30:33","modified_gmt":"2021-11-16T20:30:33","slug":"trodelvy-presente-par-therapeutic-impact","status":"publish","type":"post","link":"https:\/\/therapeutic-impact.org\/?p=973","title":{"rendered":"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact"},"content":{"rendered":"\n<div class=\"\" data-block=\"true\" data-editor=\"90d0d\" data-offset-key=\"aui46-0-0\">\n<h4 class=\"_1mf _1mj\" data-offset-key=\"aui46-0-0\"><span data-offset-key=\"aui46-0-0\"><strong><span style=\"color: #33cccc;\">Trodelvy\u00ae<\/span><\/strong><\/span><span style=\"color: #000080;\" data-offset-key=\"aui46-1-0\"> est le nouveau traitement prometteur contre le cancer du sein \u00ab triple n\u00e9gatif \u00bb qui est disponible depuis ce 1er novembre en France. Ciblant sp\u00e9cifiquement une prot\u00e9ine surexprim\u00e9e \u00e0 la surface des cellules canc\u00e9reuses, l\u2019anticorps m\u00e9dicament lib\u00e8re directement la mol\u00e9cule cytotoxique au sein de ces cellules.<\/span><\/h4>\n<h4 class=\"_1mf _1mj\" data-offset-key=\"aui46-0-0\"><span style=\"color: #000080;\" data-offset-key=\"aui46-1-0\">Des r\u00e9sultats d\u2019\u00e9tudes men\u00e9es par l&rsquo;Institut Curie ont montr\u00e9 que la m\u00e9diane de survie sans progression de ces tumeurs \u00e9tait augment\u00e9e de quatre mois et que la m\u00e9diane de survie globale \u00e9tait presque doubl\u00e9e : <\/span><\/h4>\n<h4 class=\"_1mf _1mj\" style=\"text-align: center;\" data-offset-key=\"aui46-0-0\"><span style=\"color: #000080;\" data-offset-key=\"aui46-1-0\">12,1 mois contre 6,7 mois avec la chimioth\u00e9rapie.<\/span><\/h4>\n<p><a style=\"display: inline !important;\" href=\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-984\" src=\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4-300x228.jpg\" alt=\"\" width=\"568\" height=\"432\" srcset=\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4-300x228.jpg 300w, https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4-1024x778.jpg 1024w, https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4-768x583.jpg 768w, https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg 1082w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" \/><\/a><\/p>\n<strong style=\"color: inherit;\"><span style=\"color: #33cccc;\">Sources<\/span><\/strong><\/div>\n<div class=\"\" data-block=\"true\" data-editor=\"90d0d\" data-offset-key=\"8ct6o-0-0\">\n<div class=\"_1mf _1mj\" data-offset-key=\"8ct6o-0-0\"><a href=\"https:\/\/trodelvy.com\/\"><span class=\"py34i1dx\"><span data-offset-key=\"8ct6o-0-0\">https:\/\/trodelvy.com\/<\/span><\/span><\/a><\/div>\n<\/div>\n<div class=\"\" data-block=\"true\" data-editor=\"90d0d\" data-offset-key=\"73g3a-0-0\">\n<div class=\"_1mf _1mj\" data-offset-key=\"73g3a-0-0\"><span style=\"color: #000080;\">Gupta et al., 2020. Cancer 12 :2392 (<a style=\"color: #000080;\" href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7565566\/pdf\/cancers-12-02392.pdf\"><span class=\"py34i1dx\">https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7565566\/pdf\/cancers-12-02392.pdf<\/span><\/a>) <\/span><\/div>\n<\/div>\n<div class=\"\" data-block=\"true\" data-editor=\"90d0d\" data-offset-key=\"1vm71-0-0\">\n<div class=\"_1mf _1mj\" data-offset-key=\"1vm71-0-0\"><a href=\"https:\/\/www.midilibre.fr\/2021\/11\/01\/trodelvy-quel-est-ce-nouveau-traitement-contre-le-cancer-du-sein-disponible-en-france-depuis-aujourdhui-9902860.php?fbclid=IwAR2rrdjVhlq-ySUIgG_F_mkAlxyjRx_hHvE2h5NH_is2i6jH2x3sOByX1Gk\"><span class=\"py34i1dx\"><span data-offset-key=\"1vm71-0-0\">https:\/\/www.midilibre.fr\/2021\/11\/01\/trodelvy-quel-est-ce-nouveau-traitement-contre-le-cancer-du-sein-disponible-en-france-depuis-aujourdhui-9902860.php?fbclid=IwAR2rrdjVhlq-ySUIgG_F_mkAlxyjRx_hHvE2h5NH_is2i6jH2x3sOByX1Gk<\/span><\/span><\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Trodelvy\u00ae est le nouveau traitement prometteur contre le cancer du sein \u00ab triple n\u00e9gatif \u00bb qui est disponible depuis ce 1er novembre en France.<\/p>\n","protected":false},"author":1,"featured_media":984,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[66,45],"tags":[],"class_list":["post-973","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouveaux-medicaments","category-presse"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact - Therapeutic Impact<\/title>\n<meta name=\"description\" content=\"Trodelvy\u00ae est le nouveau traitement prometteur contre le cancer du sein \u00ab triple n\u00e9gatif \u00bb qui est disponible depuis ce 1er novembre en France. Ciblant sp\u00e9cifiquement une prot\u00e9ine surexprim\u00e9e \u00e0 la surface des cellules canc\u00e9reuses, l\u2019anticorps m\u00e9dicament lib\u00e8re directement la mol\u00e9cule cytotoxique au sein de ces cellules.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/therapeutic-impact.org\/?p=973\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact - Therapeutic Impact\" \/>\n<meta property=\"og:description\" content=\"Trodelvy\u00ae est le nouveau traitement prometteur contre le cancer du sein \u00ab triple n\u00e9gatif \u00bb qui est disponible depuis ce 1er novembre en France. Ciblant sp\u00e9cifiquement une prot\u00e9ine surexprim\u00e9e \u00e0 la surface des cellules canc\u00e9reuses, l\u2019anticorps m\u00e9dicament lib\u00e8re directement la mol\u00e9cule cytotoxique au sein de ces cellules.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/therapeutic-impact.org\/?p=973\" \/>\n<meta property=\"og:site_name\" content=\"Therapeutic Impact\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Therapeutic.IMPACT\/?fref=ts\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-16T20:30:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-11-16T20:30:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1082\" \/>\n\t<meta property=\"og:image:height\" content=\"822\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"impact\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Therap_IMPACT\" \/>\n<meta name=\"twitter:site\" content=\"@Therap_IMPACT\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"impact\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973#article\",\"isPartOf\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973\"},\"author\":{\"name\":\"impact\",\"@id\":\"https:\/\/therapeutic-impact.org\/#\/schema\/person\/577c4f353c057eed508d7160e8cf916f\"},\"headline\":\"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact\",\"datePublished\":\"2021-11-16T20:30:32+00:00\",\"dateModified\":\"2021-11-16T20:30:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973\"},\"wordCount\":148,\"publisher\":{\"@id\":\"https:\/\/therapeutic-impact.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973#primaryimage\"},\"thumbnailUrl\":\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg\",\"articleSection\":[\"Nouveaux M\u00e9dicaments\",\"Presse\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973\",\"url\":\"https:\/\/therapeutic-impact.org\/?p=973\",\"name\":\"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact - Therapeutic Impact\",\"isPartOf\":{\"@id\":\"https:\/\/therapeutic-impact.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973#primaryimage\"},\"image\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973#primaryimage\"},\"thumbnailUrl\":\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg\",\"datePublished\":\"2021-11-16T20:30:32+00:00\",\"dateModified\":\"2021-11-16T20:30:33+00:00\",\"description\":\"Trodelvy\u00ae est le nouveau traitement prometteur contre le cancer du sein \u00ab triple n\u00e9gatif \u00bb qui est disponible depuis ce 1er novembre en France. Ciblant sp\u00e9cifiquement une prot\u00e9ine surexprim\u00e9e \u00e0 la surface des cellules canc\u00e9reuses, l\u2019anticorps m\u00e9dicament lib\u00e8re directement la mol\u00e9cule cytotoxique au sein de ces cellules.\",\"breadcrumb\":{\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/therapeutic-impact.org\/?p=973\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973#primaryimage\",\"url\":\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg\",\"contentUrl\":\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg\",\"width\":1082,\"height\":822,\"caption\":\"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/therapeutic-impact.org\/?p=973#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/therapeutic-impact.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/therapeutic-impact.org\/#website\",\"url\":\"https:\/\/therapeutic-impact.org\/\",\"name\":\"Therapeutic Impact\",\"description\":\"from basic research to medicinal applications\",\"publisher\":{\"@id\":\"https:\/\/therapeutic-impact.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/therapeutic-impact.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/therapeutic-impact.org\/#organization\",\"name\":\"Therapeutic Impact\",\"url\":\"https:\/\/therapeutic-impact.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/therapeutic-impact.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png\",\"contentUrl\":\"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png\",\"width\":120,\"height\":39,\"caption\":\"Therapeutic Impact\"},\"image\":{\"@id\":\"https:\/\/therapeutic-impact.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Therapeutic.IMPACT\/?fref=ts\",\"https:\/\/x.com\/Therap_IMPACT\",\"https:\/\/www.youtube.com\/channel\/UCBkbC8oHkDOTKqNHFKbTUMQ\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/therapeutic-impact.org\/#\/schema\/person\/577c4f353c057eed508d7160e8cf916f\",\"name\":\"impact\",\"url\":\"https:\/\/therapeutic-impact.org\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact - Therapeutic Impact","description":"Trodelvy\u00ae est le nouveau traitement prometteur contre le cancer du sein \u00ab triple n\u00e9gatif \u00bb qui est disponible depuis ce 1er novembre en France. Ciblant sp\u00e9cifiquement une prot\u00e9ine surexprim\u00e9e \u00e0 la surface des cellules canc\u00e9reuses, l\u2019anticorps m\u00e9dicament lib\u00e8re directement la mol\u00e9cule cytotoxique au sein de ces cellules.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/therapeutic-impact.org\/?p=973","og_locale":"fr_FR","og_type":"article","og_title":"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact - Therapeutic Impact","og_description":"Trodelvy\u00ae est le nouveau traitement prometteur contre le cancer du sein \u00ab triple n\u00e9gatif \u00bb qui est disponible depuis ce 1er novembre en France. Ciblant sp\u00e9cifiquement une prot\u00e9ine surexprim\u00e9e \u00e0 la surface des cellules canc\u00e9reuses, l\u2019anticorps m\u00e9dicament lib\u00e8re directement la mol\u00e9cule cytotoxique au sein de ces cellules.","og_url":"https:\/\/therapeutic-impact.org\/?p=973","og_site_name":"Therapeutic Impact","article_publisher":"https:\/\/www.facebook.com\/Therapeutic.IMPACT\/?fref=ts","article_published_time":"2021-11-16T20:30:32+00:00","article_modified_time":"2021-11-16T20:30:33+00:00","og_image":[{"width":1082,"height":822,"url":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg","type":"image\/jpeg"}],"author":"impact","twitter_card":"summary_large_image","twitter_creator":"@Therap_IMPACT","twitter_site":"@Therap_IMPACT","twitter_misc":{"\u00c9crit par":"impact","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/therapeutic-impact.org\/?p=973#article","isPartOf":{"@id":"https:\/\/therapeutic-impact.org\/?p=973"},"author":{"name":"impact","@id":"https:\/\/therapeutic-impact.org\/#\/schema\/person\/577c4f353c057eed508d7160e8cf916f"},"headline":"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact","datePublished":"2021-11-16T20:30:32+00:00","dateModified":"2021-11-16T20:30:33+00:00","mainEntityOfPage":{"@id":"https:\/\/therapeutic-impact.org\/?p=973"},"wordCount":148,"publisher":{"@id":"https:\/\/therapeutic-impact.org\/#organization"},"image":{"@id":"https:\/\/therapeutic-impact.org\/?p=973#primaryimage"},"thumbnailUrl":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg","articleSection":["Nouveaux M\u00e9dicaments","Presse"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/therapeutic-impact.org\/?p=973","url":"https:\/\/therapeutic-impact.org\/?p=973","name":"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact - Therapeutic Impact","isPartOf":{"@id":"https:\/\/therapeutic-impact.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/therapeutic-impact.org\/?p=973#primaryimage"},"image":{"@id":"https:\/\/therapeutic-impact.org\/?p=973#primaryimage"},"thumbnailUrl":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg","datePublished":"2021-11-16T20:30:32+00:00","dateModified":"2021-11-16T20:30:33+00:00","description":"Trodelvy\u00ae est le nouveau traitement prometteur contre le cancer du sein \u00ab triple n\u00e9gatif \u00bb qui est disponible depuis ce 1er novembre en France. Ciblant sp\u00e9cifiquement une prot\u00e9ine surexprim\u00e9e \u00e0 la surface des cellules canc\u00e9reuses, l\u2019anticorps m\u00e9dicament lib\u00e8re directement la mol\u00e9cule cytotoxique au sein de ces cellules.","breadcrumb":{"@id":"https:\/\/therapeutic-impact.org\/?p=973#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/therapeutic-impact.org\/?p=973"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/therapeutic-impact.org\/?p=973#primaryimage","url":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg","contentUrl":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2021\/11\/TRODELVY_4.jpg","width":1082,"height":822,"caption":"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact"},{"@type":"BreadcrumbList","@id":"https:\/\/therapeutic-impact.org\/?p=973#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/therapeutic-impact.org\/en\/"},{"@type":"ListItem","position":2,"name":"Trodelvy pr\u00e9sent\u00e9 par Therapeutic Impact"}]},{"@type":"WebSite","@id":"https:\/\/therapeutic-impact.org\/#website","url":"https:\/\/therapeutic-impact.org\/","name":"Therapeutic Impact","description":"from basic research to medicinal applications","publisher":{"@id":"https:\/\/therapeutic-impact.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/therapeutic-impact.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/therapeutic-impact.org\/#organization","name":"Therapeutic Impact","url":"https:\/\/therapeutic-impact.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/therapeutic-impact.org\/#\/schema\/logo\/image\/","url":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png","contentUrl":"https:\/\/therapeutic-impact.org\/wp-content\/uploads\/2016\/01\/logo-120.png","width":120,"height":39,"caption":"Therapeutic Impact"},"image":{"@id":"https:\/\/therapeutic-impact.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Therapeutic.IMPACT\/?fref=ts","https:\/\/x.com\/Therap_IMPACT","https:\/\/www.youtube.com\/channel\/UCBkbC8oHkDOTKqNHFKbTUMQ"]},{"@type":"Person","@id":"https:\/\/therapeutic-impact.org\/#\/schema\/person\/577c4f353c057eed508d7160e8cf916f","name":"impact","url":"https:\/\/therapeutic-impact.org\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/posts\/973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=973"}],"version-history":[{"count":13,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/posts\/973\/revisions"}],"predecessor-version":[{"id":988,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/posts\/973\/revisions\/988"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=\/wp\/v2\/media\/984"}],"wp:attachment":[{"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapeutic-impact.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}